Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.08% shed 0.61% to $165.70 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.12% falling 1.03% to 3,655.04 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.10% falling 1.11% to 29,260.81. The stock's fall snapped a two-day winning streak. Johnson & Johnson closed $20.99 below its 52-week high ($186.69), which the company reached on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +3.76% fell 6.77% to $307.78, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.22% fell 0.69% to $86.18, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.33% fell 0.57% to $43.83. Trading volume (8.6 M) eclipsed its 50-day average volume of 7.1 M.